Fundraising Fox

Ochre Bio

YC W20

London, GB · Founded 2019 · 50 employees · 4 known investors

ochre-bio.com ↗

Ochre Bio develops RNA therapeutics and drug discovery platforms targeting liver disease, combining proprietary human liver datasets with AI-driven causal prediction and human tissue validation models. The company aims to address the global shortage of liver transplants by developing new treatment options for liver fibrosis and cirrhosis.

AI & Machine LearningBiotechHealthtechMedical DevicesGenomicsin /ochre-bio@OchreBio

Founders & leadership· Y Combinator alumni (W20)

Quin Wills
Quin WillsinFounder/CSO
CU
Chinwe Ukomadu
ES
Elaine Sullivan
EF
Eliot Forster
JC
Jack Castle

Investors · 4

Hoxton VenturesLondon · $500K – $5M
Lifeforce CapitalChevy Chase
Y CombinatorSan Francisco · $500K – $500K
Khosla VenturesreportedMenlo Park

In the news